Evidence map›Paper›PMID 27352968›Full record

ArticleEuropean journal of human genetics : EJHG2016

Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy.

Gabrielle Rudolf, Gaetan Lesca, Mana M Mehrjouy, Audrey Labalme, Manal Salmi, Iben Bache, Nadine Bruneau, Manuela Pendziwiat, Joel Fluss, Julitta de Bellescize and 31 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Case Report: A 3' splice site variation inFrontiers in genetics · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. ROR: Nuclear Receptor for Melatonin or Not?Molecules (Basel, Switzerland) · 2021
    Review
  18. Eyelid myoclonia with absences, intellectual disability and attention deficit hyperactivity disorder: a clinical phenotype of the RORB gene mutation.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  19. Frontiers in molecular neuroscience · 2021
    Article
  20. Antiepileptogenic Effect of Retinoic Acid.Current neuropharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 8 countries.

Gabrielle RudolfIGBMC, CNRS UMR7104, INSERM U964, Strasbourg University, Strasbourg, France.
Gaetan LescaDepartment of Genetics, Lyon University Hospitals, Lyon, France.
Mana M MehrjouyDepartment of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark.
Audrey LabalmeDepartment of Genetics, Lyon University Hospitals, Lyon, France.
Manal SalmiINSERM U901, Marseille, France.
Iben BacheDepartment of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark.
Nadine BruneauINSERM U901, Marseille, France.
Manuela PendziwiatDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein (UKSH), Kiel, Germany.
Joel FlussPediatric Neurology, Child and Adolescent Department, Geneva University Hospitals, Geneva, Switzerland.
Julitta de BellescizeEpilepsy, Sleep and Pediatric Neurophysiology Department, Lyon University Hospitals, Lyon, France.
Julia SchollyDepartment of Neurology, Strasbourg University Hospital, Strasbourg, France.
Rikke S MøllerDanish Epilepsy Centre, Dianalund, Denmark.
Dana Craiu"Carol Davila" University of Medicine Bucharest, Department of Clinical Neurosciences (No.6), Pediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania.
Niels TommerupDepartment of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark.
Maria Paola Valenti-HirschDepartment of Neurology, Strasbourg University Hospital, Strasbourg, France.
Caroline Schluth-BolardDepartment of Genetics, Lyon University Hospitals, Lyon, France.
Frédérique Sloan-BénaDepartment of Medical Genetics, University Hospitals of Geneva, Geneva, Switzerland.
Katherine L HelbigDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Sarah WeckhuysenNeurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium.
Patrick EderyDepartment of Genetics, Lyon University Hospitals, Lyon, France.
Safia CoulbautUCB-Pharma, Colombes, France.
Mohamed AbbasUCB-Pharma, Colombes, France.
Ingrid E SchefferFlorey Institute, University of Melbourne, Austin Health and Royal Children's Hospital, Melbourne, Australia.
Sha TangDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Candace T MyersDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, USA.
Hannah StambergerNeurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium.
Gemma L CarvillDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, USA.
Deepali N ShindeDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Heather C MeffordDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, USA.
Elena NeaguHuman Genetics Laboratory, "Mina Minovici" National Institute of Forensic Medicine, Bucharest, Romania.
Robert HuetherDepartment of Bioinformatics, Ambry Genetics, Aliso Viejo, CA, USA.
Hsiao-Mei LuDepartment of Bioinformatics, Ambry Genetics, Aliso Viejo, CA, USA.
Alice Dica"Carol Davila" University of Medicine Bucharest, Department of Clinical Neurosciences (No.6), Pediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania.
Julie S CohenDepartment of Neurology and Developmental Medicine, Division of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.
Catrinel Iliescu"Carol Davila" University of Medicine Bucharest, Department of Clinical Neurosciences (No.6), Pediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania.
Cristina Pomeran"Carol Davila" University of Medicine Bucharest, Department of Clinical Neurosciences (No.6), Pediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania.
James RubensteinDepartment of Neurology and Developmental Medicine, Division of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.
Ingo HelbigDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein (UKSH), Kiel, Germany.
Damien SanlavilleDepartment of Genetics, Lyon University Hospitals, Lyon, France.
Edouard HirschIGBMC, CNRS UMR7104, INSERM U964, Strasbourg University, Strasbourg, France.
Pierre SzepetowskiINSERM U901, Marseille, France.
Ambry Genetics (United States) · USCarol Davila University of Medicine and Pharmacy · ROCentre de Recherche en Neurosciences de Lyon · FRUniversité de Strasbourg · FRAntwerp University Hospital · BECentre National de la Recherche Scientifique · FRChristian-Albrechts-Universität zu Kiel · DEUCB Pharma (France) · FRUniversity Hospital of Geneva · CHUniversity of Copenhagen · DKUniversity of Washington · USAix-Marseille Université · FRAustin Health · AUHospices Civils de Lyon · FRInserm · FRInstitut de Neurobiologie de la Méditerranée · FRJohns Hopkins University · USKennedy Krieger Institute · USRigshospitalet · DKSeattle University · US

Funding

Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
A Genomic Approach to EpilepsyR01NS069605 · NINDS · UNIVERSITY OF WASHINGTON · PI MEFFORD, HEATHER C. · 2010 to 2019
$4.9M
NICHD NIH HHS U54 HD083091NINDS NIH HHS R01 NS069605
6 · The paper itself

Abstract

Genetic generalized epilepsy (GGE), formerly known as idiopathic generalized epilepsy, is the most common form of epilepsy and is thought to have predominant genetic etiology. GGE are clinically characterized by absence, myoclonic, or generalized tonic-clonic seizures with electroencephalographic pattern of bilateral, synchronous, and symmetrical spike-and-wave discharges. Despite their strong heritability, the genetic basis of generalized epilepsies remains largely elusive. Nevertheless, recent advances in genetic technology have led to the identification of numerous genes and genomic defects in various types of epilepsies in the past few years. In the present study, we performed whole-exome sequencing in a family with GGE consistent with the diagnosis of eyelid myoclonia with absences. We found a nonsense variant (c.196C>T/p.(Arg66*)) in RORB, which encodes the beta retinoid-related orphan nuclear receptor (RORβ), in four affected family members. In addition, two de novo variants (c.218T>C/p.(Leu73Pro); c.1249_1251delACG/p.(Thr417del)) were identified in sporadic patients by trio-based exome sequencing. We also found two de novo deletions in patients with behavioral and cognitive impairment and epilepsy: a 52-kb microdeletion involving exons 5-10 of RORB and a larger 9q21-microdeletion. Furthermore, we identified a patient with intellectual disability and a balanced translocation where one breakpoint truncates RORB and refined the phenotype of a recently reported patient with RORB deletion. Our data support the role of RORB gene variants/CNVs in neurodevelopmental disorders including epilepsy, and especially in generalized epilepsies with predominant absence seizures.

Indexed as

AdultChildChromosome BreakpointsChromosome DeletionCodon, NonsenseDevelopmental DisabilitiesEpilepsy, GeneralizedExomeExonsFemaleHumansMaleNuclear Receptor Subfamily 1, Group F, Member 2PedigreeSyndromeTranslocation, GeneticCodon, NonsenseNuclear Receptor Subfamily 1, Group F, Member 2RORB protein, human

Identifiers

PMID27352968
PMCPMC5117930
OpenAlexW2473649727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.